Open AccessCeftriaxone treatment of syphilis
Author(s) -
Г Л Катунин,
Катунин Георгий Леонидович,
Xenia Plakhova,
Плахова Ксения Ильинична,
N. K. Abuduev,
Абудуев Назирбек Каримуллаевич,
Michael M. Vasiliev,
Васильев Михаил Михайлович
Publication year - 2021
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv1208
Subject(s) - ceftriaxone , syphilis , medicine , medline , intensive care medicine , antibiotics , family medicine , human immunodeficiency virus (hiv) , political science , microbiology and biotechnology , biology , law
The article presents literature data on the use of antibacterial drugs for the treatment of patients with syphilis, where the main focus is on ceftriaxone. Based on the materials of national and foreign studies, data on the effectiveness of ceftriaxone in the treatment of patients with various forms of syphilis have been analyzed, and information characterizing the pharmacological and pharmacokinetic features of ceftriaxone has been presented. Based on the scientific and clinical experience accumulated over previous years, both in Russia and abroad, some results of the use of ceftriaxone in the treatment of syphilis have been summed up. To search for the necessary literature, the PubMed, MedLine, Web of Science and RSCI databases were used.